[1] Hepatitis D n.d. https://www.who.int/news-room/fact-sheets/detail/hepatitis-d (accessed June 19, 2020).
[2] Le Gal F, Gault E, Ripault MP, Serpaggi J, Trinchet JC, Gordien E, et al. Eighth major clade for hepatitis delta virus. Emerg Infect Dis 2006;12:1447–50. doi:10.3201/eid1209.060112.
[3] Radjef N, Gordien E, Ivaniushina V, Gault E, Anaïs P, Drugan T, et al. Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a Deltavirus Genus of at Least Seven Major Clades. J Virol 2004;78:2537–44. doi:10.1128/jvi.78.5.2537-2544.2004.
[4] Alvarado-Mora M V., Locarnini S, Rizzetto M, Rebello Pinho JR. An update on HDV: Virology, pathogenesis and treatment. Antivir Ther 2013;18:541–8. doi:10.3851/IMP2598.
[5] WHO. World Health Organization. Global Hepatitis Report. 2017a. Glob Hepat Program Dep HIV/AIDS 2017;Disponível:14.
[6] Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012;30:2212–9. doi:10.1016/j.vaccine.2011.12.116.
[7] Abbas Z, Qureshi M, Hamid S, Jafri W. Hepatocellular carcinoma in hepatitis D: does it differ from hepatitis B monoinfection? Saudi J Gastroenterol 2012;18:18–22. doi:10.4103/1319-3767.91731.
[8] Puigvehí M, Moctezuma-Velázquez C, Villanueva A, Llovet JM. The oncogenic role of hepatitis delta virus in hepatocellular carcinoma. JHEP Reports 2019;1:120–30. doi:https://doi.org/10.1016/j.jhepr.2019.05.001.
[9] Abbas Z, Abbas M, Abbas S, Shazi L. Hepatitis D and hepatocellular carcinoma. World J Hepatol 2015;7:777–86. doi:10.4254/wjh.v7.i5.777.
[10] Stockdale AJ, Chaponda M, Beloukas A, Phillips RO, Matthews PC, Papadimitropoulos A, et al. Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Heal 2017;5:e992–1003. doi:10.1016/S2214-109X(17)30298-X.
[11] Lesbordes JL, Ravisse P, Georges AJ, Chevallier P, Pichoud C, Vitvitski L et al. No TitleStudies on the role of HDV in an outbreak of fulminant hepatitis in Bangui (Central African Republic). Prog Clin Biol Res 1987;234:451–9.
[12] Komas NP, Ghosh S, Abdou-Chekaraou M, Pradat P, Al Hawajri N, Manirakiza A, et al. Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults. PLoS Negl Trop Dis 2018;12:e0006377. doi:10.1371/journal.pntd.0006377.
[13] Ivaniushina V, Radjef N, Alexeeva M, Gault E, Semenov S, Salhi M, et al. Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia. J Gen Virol 2001;82:2709–18. doi:10.1099/0022-1317-82-11-2709.
[14] Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 2018;35:1547–9. doi:10.1093/molbev/msy096.
[15] Daw MA, Daw AM, Sifennasr NEM, Draha AM, Daw AM, Daw AM, et al. The Epidemiology of Hepatitis D Virus in North Africa : A Systematic Review and Meta-Analysis 2018;2018.
[16] Andernach IE, Leiss L V., Tarnagda ZS, Tahita MC, Otegbayo JA, Forbi JC, et al. Characterization of hepatitis delta virus in sub-Saharan Africa. J Clin Microbiol 2014;52:1629–36. doi:10.1128/JCM.02297-13.
[17] Le Gal F, Brichler S, Drugan T, Alloui C, Roulot D, Pawlotsky JM, et al. Genetic diversity and worldwide distribution of the deltavirus genus: A study of 2,152 clinical strains. Hepatology 2017;66:1826–41. doi:10.1002/hep.29574.
[18] Koyaweda Giscard Wilfried, Rose J, Machuka E, Juma J, Macharia R, Komas NP, et al. Detection of circulating hepatitis B virus immune escape and polymerase mutants among HBV-positive patients attending Institut Pasteur de Bangui, Central African Republic. Int J Infect Dis 2020;90:138–44. doi:10.1016/j.ijid.2019.10.039.
[19] Bekondi C, Olinger CM, Boua N, Talarmin A, Muller CP, Le Faou A, et al. Central African Republic is part of the West-African hepatitis B virus genotype E crescent. J Clin Virol 2007;40:31–7. doi:10.1016/j.jcv.2007.05.009.
[20] Komas NP, Vickos U, Hübschen JM, Béré A, Manirakiza A, Muller CP, et al. Cross-sectional study of hepatitis B virus infection in rural communities, Central African Republic. BMC Infect Dis 2013;13:286. doi:10.1186/1471-2334-13-286.
[21] Mulders MN, Venard V, Njayou M, Edorh AP, Bola Oyefolu AO, Kehinde MO, et al. Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 2004;190:400–8. doi:10.1086/421502.
[22] Andernach IE, Hübschen JM, Muller CP. Hepatitis B virus: The genotype E puzzle. Rev Med Virol 2009;19:231–40. doi:10.1002/rmv.618.
[23] Andernach IE, Nolte C, Pape JW, Muller CP. Slave trade and hepatitis B virus genotypes and subgenotypes in Haiti and Africa. Emerg Infect Dis 2009;15:1222–8. doi:10.3201/eid1508.081642.